跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,185 条关于
“ATTO-2306”
全部
1,185
临床试验
663
药物
367
机构
8
资讯
147
2个月前
Attovia Therapeutics Raises $289M in Upsized IPO to Advance Biparatopic Nanobody Pipeline in Immunology
去年
Attovia Therapeutics Initiates Phase 1 Trial of Novel Anti-IL-31 Therapy for Chronic Pruritus
去年
Ten Adalimumab Biosimilars Now Available in US Market Following Latest FDA Approval
去年
Blue Shield of California Slashes Humira Biosimilar Price by 75% Through Direct Purchase Model
去年
Formulary Barriers and Rebate Structures Hinder Adalimumab Biosimilar Adoption in US Market
去年
Alto Neuroscience's ALTO-300 Shows Promise in Phase 2b Trial for Major Depressive Disorder
去年
Alto Neuroscience Faces Class Action Lawsuit Following ALTO-100 Phase 2b Trial Failure
11个月前
Alto Neuroscience Receives FDA Fast Track Designation for ALTO-101 Schizophrenia Cognitive Impairment Treatment
去年
Alto Neuroscience's ALTO-100 Fails Phase 2b Trial for Major Depressive Disorder
8个月前
Alto Neuroscience Secures Key Patent for ALTO-207 Depression Treatment, Extending IP Protection to Mid-2040s
第 1 页,共 15 页
上一页
下一页